Apogee Therapeutics, Inc.
Recent Filings
All 242 filings →| Form | Description | Date |
|---|---|---|
| 4 | OWNERSHIP DOCUMENT | Mar 27, 2026 |
| SCHEDULE 13D/A | — | Mar 27, 2026 |
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 8-K | FORM 8-K | Mar 25, 2026 |
| 424B5 | 424B5 | Mar 25, 2026 |
| 144 | — | Mar 25, 2026 |
| 424B5 | 424B5 | Mar 23, 2026 |
| 8-K | FORM 8-K | Mar 23, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 13, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 6, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Henderson Jane | Chief Financial Officer | Sale | 1,500 @ $80.00 | 193,371 | Dec 19, 2025 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 560 @ $76.58 | 1,212,987 | Dec 10, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 10,900 @ $75.00 | 271,108 | Dec 4, 2025 |
| Henderson Jane | Chief Financial Officer | Sale | 1,500 @ $75.00 | 194,871 | Dec 4, 2025 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 40,000 @ $75.01 | 1,232,987 | Dec 4, 2025 |
| Henderson Jane | Chief Financial Officer | Sale | 1,500 @ $70.00 | 196,371 | Nov 25, 2025 |
| Henderson Jane | Chief Financial Officer | Sale | 2,000 @ $65.00 | 197,871 | Nov 14, 2025 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 100 @ $64.52 | 1,272,987 | Nov 13, 2025 |
| Henderson Jane | Chief Financial Officer | Sale | 1,000 @ $60.00 | 199,871 | Nov 11, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 678 @ $56.51 | 282,008 | Nov 5, 2025 |